Your browser doesn't support javascript.
loading
Improving the tolerability of osimertinib by identifying its toxic limit.
Agema, Bram C; Veerman, G D Marijn; Steendam, Christi M J; Lanser, Daan A C; Preijers, Tim; van der Leest, Cor; Koch, Birgit C P; Dingemans, Anne-Marie C; Mathijssen, Ron H J; Koolen, Stijn L W.
Afiliação
  • Agema BC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam 3015 GD, The Netherlands Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Veerman GDM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Steendam CMJ; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Lanser DAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Preijers T; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van der Leest C; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands.
  • Koch BCP; Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Dingemans AC; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Ther Adv Med Oncol ; 14: 17588359221103212, 2022.
Article em En | MEDLINE | ID: mdl-35677320

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article